Share this page

 REIJU — 2455315

Toolbar

Toolbar

Details

Third-party disclaimer

Share this page

No endorsement of any products or services is expressed or implied.

Third-party disclaimer

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Application number

2455315

Type(s)

Standard Characters

Category

Trademark

CIPO Status

SEARCHED

TM5 status

LIVE/APPLICATION/ Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.

Filed

2026-02-10

Applicant

JOHNSON & JOHNSON
One Johnson & Johnson Plaza
New Brunswick, NJ 08933
UNITED STATES OF AMERICA

Agent

GOWLING WLG (CANADA) LLP
SUITE 2600, 160 ELGIN STREET
OTTAWA
ONTARIO K1P1C3

Documents

View documents

Index headings

  • REIJU

Goods (Nice class & Statement)

5
(1) Human pharmaceutical preparations for the prevention and treatment of auto-immune diseases, cardiovascular diseases, pulmonary hypertension, pulmonary arterial hypertension, gastro-intestinal diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, cerebrovascular diseases; human pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; human pharmaceutical preparations for the prevention and treatment of neurological diseases, namely Alzheimer's, Huntington's disease, multiple sclerosis, and cerebral palsy; human pharmaceutical preparations for the prevention and treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; human pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis; Human pharmaceutical preparations for the prevention and treatment of hemolytic disease of the newborn; human pharmaceuticals preparations, namely anxiolytic medications, anti-virals, anti-inflammatories, anti-infectives, namely, antibacterials and antifungals, anti-allergic medications; human pharmaceutical preparations for the relief of pain

Action History

Actions
Action Action date Due date Comments
Filed 2026-02-10
Created 2026-02-10
Formalized 2026-02-10
Pre-Assessment Letter Sent 2026-03-05 Goods or Services Not Acceptable
Search Recorded 2026-10-20
Report a problem on this page
Date modified: